by Kall Kwik WGC | May 3, 2017 | Free Library
April, 2017 SMM-159 Reading the signals This is one of my regular Darwin’s Medicine columns and describes how you interpret the ‘weak signals’ that you see in your market to better understand and adapt your strategy.
by Kall Kwik WGC | Mar 6, 2017 | Free Library
February, 2017 SMM-158 Life Science’s Tangled Bank of Business Models The pharma industry is experiencing an explosion of new business models, more numerous and specialised than we’re used to. Companies need to pick the right model...
by Kall Kwik WGC | Mar 6, 2017 | Free Library
February, 2017 SMM-157 Six Big Shifts in Life Sciences It’s the question to which we all want the answer: Where is our industry headed? The answer is: Exactly where it is being pushed by what Charles Darwin called “immeasurably...
by Kall Kwik WGC | Mar 6, 2017 | Free Library
January, 2017 SMM-156 Strategic Symbionts Strategic alliances are becoming more interesting and more important as, increasingly, we see the emergence of symbiotic relationships as a common choice of how to compete in life...
by Kall Kwik WGC | Dec 8, 2016 | Free Library
December, 2016 SMM-154 Building the future In my previous articles in this series, I described my research findings about the forces shaping our industry (Under Pressure, PME February 2016), the 26 new business models created by those forces...
by Kall Kwik WGC | Dec 8, 2016 | Free Library
December, 2016 SMM-153 Four switches of success Very similar firms often achieve very different results. This is explained by their genetic switches.
